Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Pharmacol., 02 January 2026

Sec. Renal Pharmacology

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1764700

Correction: Nafamostat mesilate attenuates renal fibrosis by suppressing the IL-17 signaling pathway

This article is a correction to:

  1. Nafamostat mesilate attenuates renal fibrosis by suppressing the IL-17 signaling pathway

    1. Read original article
Weili Liao&#x;Weili Liao2†Rui Fan&#x;Rui Fan1†Yuman DuYuman Du1Hairong WangHairong Wang1Yong Yang Yong Yang2*Yuan Tian Yuan Tian1*
  • 1Department of Nephrology, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, China
  • 2School of Public Health, Mudanjiang Medical University, Mudanjiang, China

A Correction on
Nafamostat mesilate attenuates renal fibrosis by suppressing the IL-17 signaling pathway

by Liao W, Fan R, Du Y, Wang H, Yang Y and Tian Y (2025). Front. Pharmacol. 16:1648623. doi: 10.3389/fphar.2025.1648623

The order of Affiliations was incorrect. The correct order is:

1 Department of Nephrology, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, China.

2 School of Public Health, Mudanjiang Medical University, Mudanjiang, China.

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: renal interstitial fibrosis, Granzyme B, nafamostat mesylate, tubular injury, inflammation

Citation: Liao W, Fan R, Du Y, Wang H, Yang Y and Tian Y (2026) Correction: Nafamostat mesilate attenuates renal fibrosis by suppressing the IL-17 signaling pathway. Front. Pharmacol. 16:1764700. doi: 10.3389/fphar.2025.1764700

Received: 10 December 2025; Accepted: 11 December 2025;
Published: 02 January 2026.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2026 Liao, Fan, Du, Wang, Yang and Tian. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yuan Tian, dGlhbnl1YW5jaGVycnlAMTYzLmNvbQ==; Yong Yang, d29sZnlhbmd5QDE2My5jb20=

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.